ASN 2025: Updates to the Expanding Role of Nonsteroidal, Selective MRA’s

Stay current with rapid expert insights on recent developments in the treatment of CKD associated with diabetes presented at ASN Kidney Week 2025. Through 4 video briefs and an engaging expert panel, key opinion leaders assess new data on the evolving role of nonsteroidal, selective MRAs and the clinical application of these findings to practice.

GLC is not affiliated with ASN